Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells.

Cirone M, Lotti LV, Granato M, Renzo LD, Biunno I, Cattaneo M, Verginelli F, Vespa S, Davies D, Wells V, Mariani-Costantini R, Mallucci L.

Br J Cancer. 2019 Sep 27. doi: 10.1038/s41416-019-0561-z. [Epub ahead of print]

PMID:
31558803
2.

Carotid Body and Vagal Paragangliomas: Epidemiology, Genetics, Clinicopathological Features, Imaging, and Surgical Management.

Prasad SC, Paties CT, Pantalone MR, Mariani-Costantini R, Sanna M.

In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 5.

3.

Tympanojugular Paragangliomas: Surgical Management and Clinicopathological Features.

Prasad SC, Paties CT, Schiavi F, Esposito DL, Lotti LV, Mariani-Costantini R, Sanna M.

In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 6.

4.

Are Ouctomes of Radiosurgery for Tympanojugular Paraganglioma Overestimated?

Piras G, Mariani-Costantini R, Sanna M.

Otol Neurotol. 2019 Jun;40(5):688-689. doi: 10.1097/MAO.0000000000002221. No abstract available.

PMID:
31083102
5.

DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells.

Visone R, Bacalini MG, Di Franco S, Ferracin M, Colorito ML, Pagotto S, Laprovitera N, Licastro D, Di Marco M, Scavo E, Bassi C, Saccenti E, Nicotra A, Grzes M, Garagnani P, De Laurenzi V, Valeri N, Mariani-Costantini R, Negrini M, Stassi G, Veronese A.

Epigenomics. 2019 May 1;11(6):587-604. doi: 10.2217/epi-2018-0153. Epub 2019 May 8.

6.

Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas.

Albertini R, Mariani-Costantini R, Sanna M.

Head Neck. 2019 Aug;41(8):2835-2836. doi: 10.1002/hed.25801. Epub 2019 Apr 29. No abstract available.

PMID:
31034657
7.

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia.

Pagotto S, Veronese A, Soranno A, Balatti V, Ramassone A, Guanciali-Franchi PE, Palka G, Innocenti I, Autore F, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R.

Cancers (Basel). 2019 Apr 23;11(4). pii: E575. doi: 10.3390/cancers11040575.

8.

A Developmental Perspective on Paragangliar Tumorigenesis.

Lotti LV, Vespa S, Pantalone MR, Perconti S, Esposito DL, Visone R, Veronese A, Paties CT, Sanna M, Verginelli F, Nauclér CS, Mariani-Costantini R.

Cancers (Basel). 2019 Feb 26;11(3). pii: E273. doi: 10.3390/cancers11030273. Review.

9.

Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.

Aceto GM, Awadelkarim KD, Di Nicola M, Moscatello C, Pantalone MR, Verginelli F, Elwali NE, Mariani-Costantini R.

Breast Cancer Res Treat. 2019 Jun;175(2):479-485. doi: 10.1007/s10549-019-05168-1. Epub 2019 Feb 22.

10.

Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.

Florio R, De Lellis L, Veschi S, Verginelli F, di Giacomo V, Gallorini M, Perconti S, Sanna M, Mariani-Costantini R, Natale A, Arduini A, Amoroso R, Cataldi A, Cama A.

Sci Rep. 2018 Sep 11;8(1):13610. doi: 10.1038/s41598-018-31797-5.

11.

Correction to: Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.

Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R.

Acta Neuropathol. 2018 May;135(5):799. doi: 10.1007/s00401-018-1811-5.

PMID:
29392445
12.

Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.

Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R.

Acta Neuropathol. 2018 May;135(5):779-798. doi: 10.1007/s00401-017-1799-2. Epub 2018 Jan 5. Erratum in: Acta Neuropathol. 2018 Feb 1;:.

13.

Effects of PPARα inhibition in head and neck paraganglioma cells.

Florio R, De Lellis L, di Giacomo V, Di Marcantonio MC, Cristiano L, Basile M, Verginelli F, Verzilli D, Ammazzalorso A, Prasad SC, Cataldi A, Sanna M, Cimini A, Mariani-Costantini R, Mincione G, Cama A.

PLoS One. 2017 Jun 8;12(6):e0178995. doi: 10.1371/journal.pone.0178995. eCollection 2017.

14.

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells.

Pepe F, Pagotto S, Soliman S, Rossi C, Lanuti P, Braconi C, Mariani-Costantini R, Visone R, Veronese A.

Oncogenesis. 2017 May 8;6(5):e328. doi: 10.1038/oncsis.2017.35.

15.

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.

Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M.

Oncotarget. 2016 May 24;7(21):31361-71. doi: 10.18632/oncotarget.8913.

16.

Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma.

Vacca M, D'Amore S, Graziano G, D'Orazio A, Cariello M, Massafra V, Salvatore L, Martelli N, Murzilli S, Lo Sasso G, Mariani-Costantini R, Moschetta A.

PLoS One. 2014 Aug 12;9(8):e104449. doi: 10.1371/journal.pone.0104449. eCollection 2014.

17.

Palladium nanoparticles induce disturbances in cell cycle entry and progression of peripheral blood mononuclear cells: paramount role of ions.

Petrarca C, Clemente E, Di Giampaolo L, Mariani-Costantini R, Leopold K, Schindl R, Lotti LV, Mangifesta R, Sabbioni E, Niu Q, Bernardini G, Di Gioacchino M.

J Immunol Res. 2014;2014:295092. doi: 10.1155/2014/295092. Epub 2014 Jul 3.

18.

Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.

Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R.

World J Gastroenterol. 2014 May 28;20(20):6055-72. doi: 10.3748/wjg.v20.i20.6055. Review.

19.

The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas.

Prasad SC, Mimoune HA, D'Orazio F, Medina M, Bacciu A, Mariani-Costantini R, Piazza P, Sanna M.

Otol Neurotol. 2014 Jun;35(5):922-31. doi: 10.1097/MAO.0000000000000386.

PMID:
24751735
20.

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

Veronese A, Pepe F, Chiacchia J, Pagotto S, Lanuti P, Veschi S, Di Marco M, D'Argenio A, Innocenti I, Vannata B, Autore F, Marchisio M, Wernicke D, Verginelli F, Leone G, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R.

Leukemia. 2015 Jan;29(1):86-95. doi: 10.1038/leu.2014.139. Epub 2014 Apr 15.

21.

BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan.

Biunno I, Aceto G, Awadelkarim KD, Morgano A, Elhaj A, Eltayeb EA, Abuidris DO, Elwali NE, Spinelli C, De Blasio P, Rovida E, Mariani-Costantini R.

Fam Cancer. 2014 Sep;13(3):437-44. doi: 10.1007/s10689-014-9717-4.

PMID:
24729269
22.

Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Cama A, Verginelli F, Lotti LV, Napolitano F, Morgano A, D'Orazio A, Vacca M, Perconti S, Pepe F, Romani F, Vitullo F, di Lella F, Visone R, Mannelli M, Neumann HP, Raiconi G, Paties C, Moschetta A, Tagliaferri R, Veronese A, Sanna M, Mariani-Costantini R.

Acta Neuropathol. 2013 Oct;126(4):575-94. doi: 10.1007/s00401-013-1165-y. Epub 2013 Aug 18.

23.

Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer.

Esposito DL, Verginelli F, Toracchio S, Mammarella S, De Lellis L, Vanni C, Russo A, Mariani-Costantini R, Cama A.

Oncol Rep. 2013 Oct;30(4):1553-60. doi: 10.3892/or.2013.2626. Epub 2013 Jul 18.

24.

Distinctive gene expression profiles in Balb/3T3 cells exposed to low dose cobalt nanoparticles, microparticles and ions: potential nanotoxicological relevance.

Perconti S, Aceto GM, Verginelli F, Napolitano F, Petrarca C, Bernardini G, Raiconi G, Tagliaferri R, Sabbioni E, Di Gioacchino M, Mariani-Costantini R.

J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):443-54.

PMID:
23830394
25.

Bioinformatic pipelines in Python with Leaf.

Napolitano F, Mariani-Costantini R, Tagliaferri R.

BMC Bioinformatics. 2013 Jun 21;14:201. doi: 10.1186/1471-2105-14-201.

26.

Tissue microarray (TMA) versus whole section immunohistochemistry in the assessment of ER/PR and Her-2/neu status in a breast cancer series from Sudan.

Awadelkarim KD, Arizzi C, Elamin EO, Osman I, Mekki SO, Biunno I, Barberis MC, Mariani-Costantini R.

Breast J. 2013 Jul-Aug;19(4):446-7. doi: 10.1111/tbj.12144. Epub 2013 May 31. No abstract available.

PMID:
23721068
27.

Cytotoxicity and morphological transforming potential of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts: an in vitro model.

Sabbioni E, Fortaner S, Farina M, Del Torchio R, Olivato I, Petrarca C, Bernardini G, Mariani-Costantini R, Perconti S, Di Giampaolo L, Gornati R, Di Gioacchino M.

Nanotoxicology. 2014 Jun;8(4):455-64. doi: 10.3109/17435390.2013.796538. Epub 2013 May 15.

PMID:
23586465
28.

Diagnosis: Breast cancer screening in rural African communities.

Mariani-Costantini R.

Nat Rev Clin Oncol. 2013 Apr;10(4):185-6. doi: 10.1038/nrclinonc.2013.38. Epub 2013 Mar 12. No abstract available.

PMID:
23478282
29.

Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.

Vacca M, Murzilli S, Salvatore L, Di Tullio G, D'Orazio A, Lo Sasso G, Graziano G, Pinzani M, Chieppa M, Mariani-Costantini R, Palasciano G, Moschetta A.

Gastroenterology. 2013 Jun;144(7):1518-1529.e3. doi: 10.1053/j.gastro.2013.02.027. Epub 2013 Feb 24.

PMID:
23462179
30.

Interaction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts.

Sabbioni E, Fortaner S, Farina M, Del Torchio R, Petrarca C, Bernardini G, Mariani-Costantini R, Perconti S, Di Giampaolo L, Gornati R, Di Gioacchino M.

Nanotoxicology. 2014 Feb;8(1):88-99. doi: 10.3109/17435390.2012.752051. Epub 2012 Dec 21.

PMID:
23167736
31.

Nuclear receptors in regenerating liver and hepatocellular carcinoma.

Vacca M, Degirolamo C, Massafra V, Polimeno L, Mariani-Costantini R, Palasciano G, Moschetta A.

Mol Cell Endocrinol. 2013 Apr 10;368(1-2):108-19. doi: 10.1016/j.mce.2012.06.025. Epub 2012 Jul 9. Review.

PMID:
22789748
32.

Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.

Mallucci L, Shi DY, Davies D, Jordan P, Nicol A, Lotti L, Mariani-Costantini R, Verginelli F, Wells V, Zicha D.

Mol Cancer Ther. 2012 Sep;11(9):1884-93. doi: 10.1158/1535-7163.MCT-11-1041-T. Epub 2012 Jul 2.

33.

The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

Esposito DL, Aru F, Lattanzio R, Morgano A, Abbondanza M, Malekzadeh R, Bishehsari F, Valanzano R, Russo A, Piantelli M, Moschetta A, Lotti LV, Mariani-Costantini R.

PLoS One. 2012;7(4):e36190. doi: 10.1371/journal.pone.0036190. Epub 2012 Apr 27.

34.

Analysis of gene copy number variations using a method based on lab-on-a-chip technology.

De Lellis L, Mammarella S, Curia MC, Veschi S, Mokini Z, Bassi C, Sala P, Battista P, Mariani-Costantini R, Radice P, Cama A.

Tumori. 2012 Jan-Feb;98(1):126-36. doi: 10.1700/1053.11511.

PMID:
22495713
35.

SEL1L, an UPR response protein, a potential marker of colonic cell transformation.

Ashktorab H, Green W, Finzi G, Sessa F, Nouraie M, Lee EL, Morgano A, Moschetta A, Cattaneo M, Mariani-Costantini R, Brim H, Biunno I.

Dig Dis Sci. 2012 Apr;57(4):905-12. doi: 10.1007/s10620-011-2026-y. Epub 2012 Feb 16.

36.

Increased variance in germline allele-specific expression of APC associates with colorectal cancer.

Curia MC, De Iure S, De Lellis L, Veschi S, Mammarella S, White MJ, Bartlett J, Di Iorio A, Amatetti C, Lombardo M, Di Gregorio P, Battista P, Mariani-Costantini R, Williams SM, Cama A.

Gastroenterology. 2012 Jan;142(1):71-77.e1. doi: 10.1053/j.gastro.2011.09.048. Epub 2011 Oct 10.

37.

Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women.

Reale M, Vianale G, Lotti LV, Mariani-Costantini R, Perconti S, Cristaudo A, Leopold K, Antonucci A, Di Giampaolo L, Iavicoli I, Di Gioacchino M, Boscolo P.

J Occup Environ Med. 2011 Sep;53(9):1054-60. doi: 10.1097/JOM.0b013e318228115e.

PMID:
21866053
38.

Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome.

Vacca M, Degirolamo C, Mariani-Costantini R, Palasciano G, Moschetta A.

Wiley Interdiscip Rev Syst Biol Med. 2011 Sep-Oct;3(5):562-87. doi: 10.1002/wsbm.137. Epub 2011 Feb 16. Review.

PMID:
21755605
39.

Immunotoxicity of nanoparticles.

Di Gioacchino M, Petrarca C, Lazzarin F, Di Giampaolo L, Sabbioni E, Boscolo P, Mariani-Costantini R, Bernardini G.

Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl):65S-71S. Review.

PMID:
21329568
40.

Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cells.

Cattaneo M, Lotti LV, Martino S, Alessio M, Conti A, Bachi A, Mariani-Costantini R, Biunno I.

PLoS One. 2011 Feb 17;6(2):e17206. doi: 10.1371/journal.pone.0017206.

41.

Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations.

Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De Blasio P, Mekki SO, Osman I, Biunno I, Elwali NE, Barberis MC, Mariani-Costantini R.

Patholog Res Int. 2011 Jan 9;2011:806831. doi: 10.4061/2011/806831.

42.

Cancer in the Sudan: an overview of the current status of knowledge on tumor patterns and risk factors.

Awadelkarim KD, Mariani-Costantini R, Elwali NE.

Sci Total Environ. 2012 Apr 15;423:214-28. doi: 10.1016/j.scitotenv.2010.09.010. Epub 2010 Nov 10. Review.

PMID:
21071068
43.

Environment and immune-mediated diseases in Sub-Saharan Africa.

Elwali NE, Mariani Costantini R, Di Gioacchino M.

Sci Total Environ. 2012 Apr 15;423:190-2. doi: 10.1016/j.scitotenv.2010.08.044. Epub 2010 Oct 18. No abstract available.

PMID:
20961598
44.

Report on the 6th African Society of Human Genetics (AfSHG) Meeting, March 12-15, 2009, Yaounde, Cameroon.

Sirugo G, Williams SM, Royal CD, Newport MJ, Hennig BJ, Mariani-Costantini R, Buonaguro FM, Velez Edwards DR, Ibrahim M, Soodyall H, Wonkam A, Ramesar R, Rotimi CN.

Am J Trop Med Hyg. 2010 Aug;83(2):226-9. doi: 10.4269/ajtmh.2010.10-0208.

45.

Association of the DSS1 c.143G>A polymorphism with skin squamous cell carcinoma.

Venza M, Catalano T, Visalli M, Venza I, Lentini M, Curia MC, Mariani-Costantini R, Teti D.

J Invest Dermatol. 2010 Jun;130(6):1719-25. doi: 10.1038/jid.2010.21. Epub 2010 Mar 11.

46.

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.

Aceto GM, Solano AR, Neuman MI, Veschi S, Morgano A, Malatesta S, Chacon RD, Pupareli C, Lombardi M, Battista P, Marchetti A, Mariani-Costantini R, Podestà EJ.

Breast Cancer Res Treat. 2010 Aug;122(3):671-83. doi: 10.1007/s10549-009-0596-6. Epub 2009 Oct 23.

PMID:
19851859
47.

The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors.

Modica S, Gofflot F, Murzilli S, D'Orazio A, Salvatore L, Pellegrini F, Nicolucci A, Tognoni G, Copetti M, Valanzano R, Veschi S, Mariani-Costantini R, Palasciano G, Schoonjans K, Auwerx J, Moschetta A.

Gastroenterology. 2010 Feb;138(2):636-48, 648.e1-12. doi: 10.1053/j.gastro.2009.09.060. Epub 2009 Oct 8.

PMID:
19818784
48.

Transitions at CpG dinucleotides, geographic clustering of TP53 mutations and food availability patterns in colorectal cancer.

Verginelli F, Bishehsari F, Napolitano F, Mahdavinia M, Cama A, Malekzadeh R, Miele G, Raiconi G, Tagliaferri R, Mariani-Costantini R.

PLoS One. 2009 Aug 31;4(8):e6824. doi: 10.1371/journal.pone.0006824.

49.

Nutrigenetics in the light of human evolution.

Verginelli F, Aru F, Battista P, Mariani-Costantini R.

J Nutrigenet Nutrigenomics. 2009;2(2):91-102. doi: 10.1159/000228251. Epub 2009 Jul 10. Review.

PMID:
19690436
50.

Nonfluorescent denaturing HPLC-based primer-extension method for allele-specific expression: application to analysis of mismatch repair genes.

Aceto GM, De Lellis L, Catalano T, Veschi S, Radice P, Di Iorio A, Mariani-Costantini R, Cama A, Curia MC.

Clin Chem. 2009 Sep;55(9):1711-8. doi: 10.1373/clinchem.2009.126300. Epub 2009 Jul 23.

Supplemental Content

Loading ...
Support Center